Drug Shortage Report for SANDOZ LISDEXAMFETAMINE CAPSULES

Last updated on 2024-10-22

Report ID 240305
Drug Identification Number 02546248
Brand name SANDOZ LISDEXAMFETAMINE CAPSULES
Common or Proper name LISDEXAMFETAMINE CAPSULES
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) LISDEXAMFETAMINE DIMESYLATE
Strength(s) 10MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100HGC
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2024-10-15
Estimated end date 2024-10-25
Actual end date 2024-10-21
Shortage status Resolved
Updated date 2024-10-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2024-10-22 English Compare
v7 2024-10-21 French Compare
v6 2024-10-21 English Compare
v5 2024-10-15 French Compare
v4 2024-10-15 English Compare
v3 2024-10-15 English Compare
v2 2024-10-15 English Compare
v1 2024-10-15 English Compare

Showing 1 to 8 of 8